Anti-tumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo

被引：0
|
作者：
Ray, J. [1 ]
Ralff, M. [1 ]
Jhaveri, A. [2 ]
El-Deiry, W. [2 ]
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.06.158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
85
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [31] ONC201 in combination with carboplatin and etoposide as a novel triple drug treatment for small cell lung cancer (SCLC)
    Lee, Young S.
    Zhou, Lanlan
    Azzoli, Christopher
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
  • [32] MDM2 inhibition in combination with imipridone ONC201 treatment as a synergistic combination in solid tumors
    George, Andrew
    Sahin, Ilyas
    Zhang, Shengliang
    Schwermann, Maximilian
    Di Cristofano, Francesca
    DeGeorge, Charlotte
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2023, 83 (07)
  • [33] Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
    Staley, Allison
    Tucker, Katherine
    Yin, Yajie
    Zhang, Xin
    Fan, Yali
    Zhang, Yingao
    Fang, Ziwei
    Sun, Wenchuan
    Suo, Hongyan
    Zhao, Xiaoling
    Zhao, Ziyi
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5374 - +
  • [34] Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
    Staley, A.
    Tucker, K.
    Fang, Z.
    Fan, Y.
    Sun, W.
    Yin, Y.
    Zhang, Y.
    Prabhu, V. V.
    Allen, J. E.
    Stogniew, M.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 224 - 224
  • [35] ONC201 sensitizes resistant breast cancer cells to TRAIL through death receptor 5 upregulation
    Ralff, Marie D.
    Wagner, Jessica
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] ONC213, a Novel Second Generation Analog of ONC201, Shows Promising Anti-Leukemic Activity Against AML Cells In Vitro and In Vivo
    Su, Yongwei
    Li, Xinyu
    Edwards, Holly
    Allen, Joshua E.
    Stogniew, Martin
    Prabhu, Varun Vijay
    Taub, Jeffrey W.
    Lin, Hai
    Ge, Yubin
    BLOOD, 2017, 130
  • [37] Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study
    Feng, Yuan
    Zhou, Jihong
    Li, Zhanhua
    Jiang, Ying
    Zhou, Ying
    PLOS ONE, 2016, 11 (09):
  • [38] Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivo
    Jhaveri, Aakash, V
    Zhou, Lanlan
    Ralff, Marie D.
    Lee, Young S.
    Navaraj, Arunasalam
    Carneiro, Benedito A.
    Safran, Howard
    Prabhu, Varun V.
    Ross, Eric A.
    Lee, Seulki
    El-Deiry, Wafik S.
    CANCER BIOLOGY & THERAPY, 2021, 22 (10-12) : 607 - 618
  • [39] Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer
    Cui, Hao
    Hu, Zan
    Yang, Kang
    Huang, Jingkun
    Wu, Yichao
    Chen, Quanwei
    Wei, Ran
    Wang, Penfeng
    Wang, Hui
    Li, Hongmei
    Chen, Yadong
    Lu, Tao
    Yao, Yuqin
    Zhu, Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 238
  • [40] Anti-tumorigenic activity of sophoflavescenol against Lewis lung carcinoma in vitro and in vivo
    Hyun Ah Jung
    Seong Eun Jin
    Ran Joo Choi
    Hung Tran Manh
    Yeong Shik Kim
    Byung-Sun Min
    You Kyung Son
    Bo Ra Ahn
    Byung-Woo Kim
    Hee Sook Sohn
    Jae Sue Choi
    Archives of Pharmacal Research, 2011, 34 : 2087 - 2099
12345